Smithbridge Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
10,048
-470
-4% -$55K 0.18% 94
2026
Q1
$1.27M Buy
10,518
+2,404
+30% +$278K 0.19% 100
2025
Q4
$854K Buy
+8,114
New +$762K 0.07% 112
2025
Q2
Sell
-2,489
Closed -$223K 124
2025
Q1
$223K Buy
+2,489
New +$232K 0.04% 122
2024
Q3
$302K Sell
2,655
-150
-5% -$17.8K 0.05% 121
2024
Q2
$347K Buy
2,805
+166
+6% +$21.4K 0.07% 121
2024
Q1
$348K Hold
2,639
0.07% 120
2023
Q4
$288K Sell
2,639
-115
-4% -$11.9K 0.07% 125
2023
Q3
$284K Buy
2,754
+250
+10% +$26.9K 0.07% 125
2023
Q2
$289K Buy
2,504
+115
+5% +$13.1K 0.07% 125
2023
Q1
$254K Buy
+2,389
New +$258K 0.06% 127

Other funds holding MRK

Smithbridge Asset Management's MRK Position: Q2 2026 in Review

Smithbridge Asset Management reduced its Merck (MRK) stake by 4.5% in Q2 2026, selling an estimated $55K and leaving 10,048 shares worth $1.29M. The position accounts for 0.18% of the portfolio, ranked #94.

Smithbridge Asset Management first reported a position in MRK in Q1 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Smithbridge Asset Management held 10,048 shares of Merck worth $1.29M as of Q2 2026.
  • Smithbridge Asset Management sold 470 Merck shares in Q2 2026, an estimated $55K.
  • Merck made up 0.18% of Smithbridge Asset Management's portfolio in Q2 2026, its #94 holding.
  • Smithbridge Asset Management first reported a position in Merck in Q1 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Smithbridge Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.